These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus? Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707 [TBL] [Abstract][Full Text] [Related]
23. [Endoluminal therapy of neoplastic changes in the gastrointestinal tract: Barrett esophagus--from the viewpoint of the surgeon]. Stein HJ; Feith M; Siewert JR Kongressbd Dtsch Ges Chir Kongr; 2001; 118():147-51. PubMed ID: 11824235 [TBL] [Abstract][Full Text] [Related]
24. [Barrett esophagus: ablative methods of treatment]. Jung M; Ell C Internist (Berl); 2003 Jan; 44(1):52-7. PubMed ID: 12677705 [No Abstract] [Full Text] [Related]
26. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. Whitson MJ; Falk GW Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196 [TBL] [Abstract][Full Text] [Related]
27. [Barrett's neoplasia: where is the problem?]. Krugmann J; Vieth M; Neumann H Zentralbl Chir; 2014 Aug; 139(4):386-92. PubMed ID: 25119577 [TBL] [Abstract][Full Text] [Related]
29. Future developments in total Barrett's eradication: the surgeon's view. Watson TJ; Peters JH Endoscopy; 2008 Dec; 40(12):1048-51. PubMed ID: 19065490 [TBL] [Abstract][Full Text] [Related]
30. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study. Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and risk factors associated with specialized intestinal metaplasia at the esophagogastric junction. Kamberoglou DK; Savva SC; Kalapothakos PN; Koukounas ND; Doulgeroglou VG; Patra EG; Tzias VD Hepatogastroenterology; 2002; 49(46):995-8. PubMed ID: 12143262 [TBL] [Abstract][Full Text] [Related]
32. Advanced endoscopic therapeutics in Barrett's neoplasia: where are we now and where are we heading? Longcroft-Wheaton G; Bhandari P Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):543-5. PubMed ID: 25850665 [TBL] [Abstract][Full Text] [Related]